• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Not Available].

作者信息

Jommi Claudio, Patarnello Francesca, Bianchi Cosetta, Buzzetti Giuliano

机构信息

Dipartimento di Scienze del Farmaco, Università del Piemonte Orientale, Novara - Italy.

Market Access & Government Affairs, AstraZeneca, Milano - Italy.

出版信息

Glob Reg Health Technol Assess. 2024 Jul 15;11:169-174. doi: 10.33393/grhta.2024.3107. eCollection 2024 Jan-Dec.

DOI:10.33393/grhta.2024.3107
PMID:39015812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11250006/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/155c/11250006/d724e693ac8f/grhta-11-169_g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/155c/11250006/d724e693ac8f/grhta-11-169_g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/155c/11250006/d724e693ac8f/grhta-11-169_g001.jpg

相似文献

1
[Not Available].[无可用内容]。
Glob Reg Health Technol Assess. 2024 Jul 15;11:169-174. doi: 10.33393/grhta.2024.3107. eCollection 2024 Jan-Dec.

本文引用的文献

1
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy.从基于适应症定价到混合定价法：意大利药品价格与报销谈判的证据
Pharmacoecon Open. 2024 Mar;8(2):251-261. doi: 10.1007/s41669-023-00467-2. Epub 2024 Jan 16.
2
A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems.在技术变革和经济挑战环境下，为公共资助医疗系统制定基于价值的管理式准入协议的提案。
Front Med Technol. 2022 Jun 16;4:888404. doi: 10.3389/fmedt.2022.888404. eCollection 2022.
3
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework - Corrigendum.促进创新疗法更高效的谈判：基于价值的谈判框架——勘误
Int J Technol Assess Health Care. 2022 May 24;38(1):e43. doi: 10.1017/S0266462322000290.
4
Pharmaceutical net price transparency across european markets: Insights from a multi-agent simulation model.药品在欧洲市场的实际价格透明度：来自多主体仿真模型的分析。
Health Policy. 2022 Jun;126(6):534-540. doi: 10.1016/j.healthpol.2022.03.013. Epub 2022 Mar 31.
5
Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results.估算药物研发行业投资成本：方法与结果综述。
Inquiry. 2021 Jan-Dec;58:469580211059731. doi: 10.1177/00469580211059731.
6
Building HTA insights into the drug development plan: Current approaches to seeking early scientific advice from HTA agencies.将 HTA 洞察融入药物开发计划：寻求 HTA 机构早期科学建议的当前方法。
Drug Discov Today. 2022 Jan;27(1):347-353. doi: 10.1016/j.drudis.2021.09.014. Epub 2021 Sep 28.
7
International reference pricing for prescription drugs: a landscape analysis.国际处方药参考定价：全景分析。
J Manag Care Spec Pharm. 2021 Sep;27(9):1309-1313. doi: 10.18553/jmcp.2021.27.9.1309.
8
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment.研究和开发一种新药需要多少钱？系统评价和评估。
Pharmacoeconomics. 2021 Nov;39(11):1243-1269. doi: 10.1007/s40273-021-01065-y. Epub 2021 Aug 9.
9
Establishing a reasonable price for an orphan drug.为孤儿药制定合理价格。
Cost Eff Resour Alloc. 2020 Sep 4;18:31. doi: 10.1186/s12962-020-00223-x. eCollection 2020.
10
Pricing of pharmaceuticals is becoming a major challenge for health systems.药品定价正成为卫生系统面临的一项重大挑战。
BMJ. 2020 Jan 13;368:l4627. doi: 10.1136/bmj.l4627.